» Articles » PMID: 30865475

Clinical Efficacy of Pinhole Soft Contact Lenses for the Correction of Presbyopia

Overview
Publisher Informa Healthcare
Specialty Ophthalmology
Date 2019 Mar 14
PMID 30865475
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the clinical efficacy of pinhole soft contact lenses for presbyopia correction. Twenty participants with presbyopia wore pinhole soft contact lenses in the non-dominant eye for 2 weeks. Manifest refraction, Goldmann binocular visual field tests, contrast sensitivity tests, and biomicroscopic examinations were performed along with evaluations of questionnaire responses and the binocular corrected distance visual acuity (CDVA), distance-corrected near visual acuity (DCNVA), distance-corrected intermediate visual acuity (DCIVA), and depth of focus, both before and after 2 weeks of lens wear. DCNVA at 33 and 40 cm and DCIVA at 50 and 70 cm showed significant improvements after pinhole lens wear (P-value: <0.001, <0.001, <0.001, and 0.046, respectively), with no changes in the binocular visual field and binocular CDVA. Contrast sensitivities under photopic and mesopic conditions decreased at some frequencies; however, visual function questionnaire scores significantly improved (all P-values <0.001). These findings suggest that pinhole contact lenses effectively correct presbyopia.

Citing Articles

Pilocarpine in the Treatment of Presbyopia: Progress, Issues, and Future Prospects.

Zhang X, Xiong X, Zhang H, Huang T, Zhou X Drugs Aging. 2024; 41(11):897-906.

PMID: 39455529 DOI: 10.1007/s40266-024-01155-4.


Efficacy of a new refractive multifocal contact lens for presbyopia.

Kim D, Ahn H, Lee S, Jun I, Seo K, Kim S Sci Rep. 2024; 14(1):8878.

PMID: 38632261 PMC: 11024154. DOI: 10.1038/s41598-024-55918-5.


New insights in presbyopia: impact of correction strategies.

Wolffsohn J, Davies L, Sheppard A BMJ Open Ophthalmol. 2023; 8(1).

PMID: 37278419 PMC: 9887707. DOI: 10.1136/bmjophth-2022-001122.


Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.

Pepose J, Hartman P, DuBiner H, Abrams M, Smyth-Medina R, Moroi S Clin Ophthalmol. 2021; 15:79-91.

PMID: 33447013 PMC: 7802916. DOI: 10.2147/OPTH.S278169.